Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long-Term Benzodiazepine Use in Insomnia and Anxiety Disorders.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
28 09 2021
Historique:
received: 27 07 2021
revised: 15 09 2021
accepted: 23 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 26 10 2021
Statut: epublish

Résumé

Benzodiazepines have proven to be highly effective for treating insomnia and anxiety. Although considered safe when taken for a short period of time, a major risk-benefit dilemma arises in the context of long-term use, relating to addiction, withdrawal symptoms, and potential side effects. For these reasons, benzodiazepines are not recommended for treating chronic sleep disorders, anxiety disorders, nor for people over the age of 65, and withdrawal among long-term users is a public health issue. Indeed, only 5% of patients manage to discontinue using these drugs on their own. Even with the help of a general practitioner, this rate does not exceed 25 to 30% of patients, of which approximately 7% manage to remain drug-free in the long term. Cognitive Behavioral Therapies (CBT) offer a crucial solution to this problem, having been shown to increase abstinence success to 70-80%. This article examines traditional and novel CBT techniques in this regard, such as Acceptance and Commitment Therapy, which address both the underlying condition (insomnia/anxiety) and the substance-related disorder. The theoretical framework and evidence supporting the use of these approaches are reviewed. Finally, current research gaps are discussed, and key research perspectives are proposed.

Identifiants

pubmed: 34639523
pii: ijerph181910222
doi: 10.3390/ijerph181910222
pmc: PMC8508349
pii:
doi:

Substances chimiques

Benzodiazepines 12794-10-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Int Clin Psychopharmacol. 2007 Sep;22(5):292-8
pubmed: 17690598
Am J Psychiatry. 1994 Jun;151(6):876-81
pubmed: 8184997
Addiction. 2009 Jan;104(1):13-24
pubmed: 18983627
BMC Res Notes. 2012 Dec 13;5:684
pubmed: 23237104
Eur Psychiatry. 2012 May;27(4):301-7
pubmed: 21334859
Int Rev Psychiatry. 2014 Apr;26(2):205-13
pubmed: 24892895
Expert Opin Drug Saf. 2014 Jul;13(7):919-34
pubmed: 24905348
J Am Geriatr Soc. 2015 Oct;63(10):2074-81
pubmed: 26415836
Sleep Med Rev. 2016 Dec;30:1-10
pubmed: 26615572
Psychol Med. 1998 May;28(3):713-20
pubmed: 9626727
Eur J Clin Pharmacol. 2002 Jan;57(11):759-64
pubmed: 11868796
Nicotine Tob Res. 2014 Nov;16(11):1446-54
pubmed: 24935757
Arch Gen Psychiatry. 1990 Oct;47(10):908-15
pubmed: 2222130
Br J Psychiatry. 2003 Jun;182:498-504
pubmed: 12777340
Br J Gen Pract. 2011 Sep;61(590):e573-8
pubmed: 22152740
Psychiatry Clin Neurosci. 2021 Apr;75(4):119-127
pubmed: 33448517
Dtsch Arztebl Int. 2015 Jan 5;112(1-2):1-7
pubmed: 25613443
Psychother Psychosom. 2006;75(4):220-8
pubmed: 16785771
J Consult Clin Psychol. 2007 Apr;75(2):325-35
pubmed: 17469890
Clin Psychol Rev. 2014 Mar;34(2):130-40
pubmed: 24487344
Drugs Aging. 2015 Dec;32(12):1009-18
pubmed: 26547856
Behav Res Ther. 2010 Aug;48(8):720-7
pubmed: 20546699
Am J Geriatr Psychiatry. 2016 Nov;24(11):1063-1073
pubmed: 27687212
Cochrane Database Syst Rev. 2016 Apr 13;4:CD011004
pubmed: 27071857
Lancet. 1988 Aug 27;2(8609):504-5
pubmed: 2900421
Science. 2013 Feb 15;339(6121):814-5
pubmed: 23413353
Scand J Psychol. 2017 Jun;58(3):211-220
pubmed: 28543320
J Psychopharmacol. 2013 Nov;27(11):967-71
pubmed: 24067791
Drug Alcohol Depend. 2003 Jun 5;70(3):309-14
pubmed: 12757968
Behav Res Ther. 2012 Nov;50(11):651-60
pubmed: 22975073
Int Clin Psychopharmacol. 2015 Jul;30(4):183-92
pubmed: 25932596
Sleep Med Rev. 2020 Dec;54:101351
pubmed: 32739824
Br Med J (Clin Res Ed). 1981 Sep 5;283(6292):643-5
pubmed: 6114776
Br J Psychiatry. 1990 Mar;156:406-11
pubmed: 1971767
CNS Drugs. 2016 Jan;30(1):1-7
pubmed: 26715389
Psychopharmacology (Berl). 2003 May;167(3):297-303
pubmed: 12669174
Br J Psychiatry. 1989 Apr;154:529-34
pubmed: 2686797
Br J Clin Pharmacol. 2014 Jun;77(6):975-85
pubmed: 24286360
Psychiatr Danub. 2011 Mar;23(1):76-8
pubmed: 21448102
Behav Cogn Psychother. 2017 Mar;45(2):110-123
pubmed: 28229805
Eur J Clin Pharmacol. 2017 Aug;73(8):927-935
pubmed: 28456823
Arch Gen Psychiatry. 1990 Oct;47(10):899-907
pubmed: 2222129
Sleep. 2006 Nov;29(11):1398-414
pubmed: 17162986
Am J Public Health. 2016 Apr;106(4):686-8
pubmed: 26890165
Neuropsychiatr Dis Treat. 2018 May 23;14:1351-1361
pubmed: 29872302
Br Med J (Clin Res Ed). 1982 Mar 27;284(6320):942
pubmed: 6121606
Addiction. 2008 Apr;103(4):662-70
pubmed: 18339112
Am J Health Promot. 1997 Sep-Oct;12(1):38-48
pubmed: 10170434
J Gen Intern Med. 2007 Sep;22(9):1335-50
pubmed: 17619935
J Clin Psychiatry. 2002 Sep;63(9):756-7
pubmed: 12363113
Sleep Med Rev. 2015 Oct;23:54-67
pubmed: 25645130
Clin Pharmacol Ther. 2011 Apr;89(4):595-601
pubmed: 21368756
BMC Neurol. 2020 Aug 13;20(1):300
pubmed: 32791960
Br J Gen Pract. 1990 Jun;40(335):261
pubmed: 2117954
Cochrane Database Syst Rev. 2015;(5):CD009652
pubmed: 26106751
Addict Behav. 2020 Mar;102:106195
pubmed: 31838367
Front Psychol. 2018 Sep 21;9:1764
pubmed: 30298037
Br J Gen Pract. 1994 Sep;44(386):408-12
pubmed: 8790654
Lancet. 2019 Feb 23;393(10173):768-777
pubmed: 30712879
Sleep Med Rev. 2004 Feb;8(1):47-62
pubmed: 15062210
Br J Psychiatry. 2014 Feb;204(2):98-107
pubmed: 24493654
Am J Psychiatry. 1993 Oct;150(10):1485-90
pubmed: 8379551
JAMA Intern Med. 2014 Jun;174(6):890-8
pubmed: 24733354
World J Biol Psychiatry. 2016 Oct;17(7):514-24
pubmed: 26086792
Behav Res Ther. 1999 Nov;37(11):1029-54
pubmed: 10500319
J Consult Clin Psychol. 2006 Oct;74(5):908-19
pubmed: 17032095
Sleep Med Rev. 2021 Apr;56:101415
pubmed: 33529781
J Clin Psychiatry. 2008 Apr;69(4):621-32
pubmed: 18363421
Neurol Sci. 2017 Jan;38(1):137-142
pubmed: 27730361
Behav Ther. 2016 Nov;47(6):869-885
pubmed: 27993338
Behav Res Ther. 2013 Dec;51(12):787-96
pubmed: 24121096
J Med Internet Res. 2019 Jan 29;21(1):e12530
pubmed: 30694201
Eur Psychiatry. 1995;10 Suppl 3:145s-51s
pubmed: 19698411
J Consult Clin Psychol. 1996 Dec;64(6):1152-68
pubmed: 8991302
Behav Res Ther. 2005 Jan;43(1):1-14
pubmed: 15531349
Fam Pract. 2011 Jun;28(3):253-9
pubmed: 21193495
Arch Intern Med. 2004 Sep 27;164(17):1888-96
pubmed: 15451764
Sleep Med Rev. 2019 Dec;48:101214
pubmed: 31648145
JAMA Psychiatry. 2015 Feb;72(2):136-42
pubmed: 25517224
J Clin Psychopharmacol. 1989 Jun;9(3):161-72
pubmed: 2567741
Addict Behav. 1999 Jul-Aug;24(4):537-41
pubmed: 10466848
Psychol Med. 2003 Apr;33(3):511-8
pubmed: 12701671
J Clin Med Res. 2020 Oct;12(10):629-633
pubmed: 33029268
Int Rev Psychiatry. 2005 Jun;17(3):189-97
pubmed: 16194790
Int Clin Psychopharmacol. 1999 Sep;14(5):287-303
pubmed: 10529072
PLoS One. 2016 Aug 12;11(8):e0161248
pubmed: 27517450
Eur J Clin Pharmacol. 2001 Aug;57(5):419-25
pubmed: 11599660
Epidemiol Psychiatr Sci. 2016 Jun;25(3):214-6
pubmed: 26818890
Cochrane Database Syst Rev. 2016 Mar 12;3:CD011565
pubmed: 26968204
Drug Alcohol Depend. 2005 Apr 4;78(1):49-56
pubmed: 15769557
Can J Psychiatry. 1981 Mar;26(2):93-5
pubmed: 6114793
J Psychosom Res. 2015 May;78(5):427-432
pubmed: 25498318
Sleep Med. 2008 Dec;9(8):818-22
pubmed: 18226959
Pharmacology. 1983;26(3):121-37
pubmed: 6132413
Chemosphere. 2017 Jun;176:324-332
pubmed: 28273540
Age Ageing. 2010 May;39(3):313-9
pubmed: 20089547
CMAJ. 2003 Nov 11;169(10):1015-20
pubmed: 14609970
Clin Psychol Rev. 2013 Dec;33(8):965-78
pubmed: 23999201
Am J Psychiatry. 2004 Feb;161(2):332-42
pubmed: 14754783
Pain Pract. 2020 Jan;20(1):44-54
pubmed: 31336019
Expert Opin Pharmacother. 2012 Jan;13(1):9-16
pubmed: 22107732
JAMA. 2006 Jun 28;295(24):2851-8
pubmed: 16804151
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):539-40
pubmed: 16950552
Lancet. 1983 Jun 25;1(8339):1402-6
pubmed: 6134180
Cochrane Database Syst Rev. 2003;(1):CD003161
pubmed: 12535460
J Consult Clin Psychol. 1999 Feb;67(1):151-6
pubmed: 10028220
Br J Addict. 1987 Dec;82(12):1317-27
pubmed: 2892523
Br J Gen Pract. 1994 Jan;44(378):5-8
pubmed: 8312045
J Sleep Res. 2021 Feb;30(1):e13199
pubmed: 33020985
Pharm World Sci. 2007 Dec;29(6):641-6
pubmed: 17610043
Can Fam Physician. 2018 May;64(5):e209-e224
pubmed: 29760269
Eur J Obstet Gynecol Reprod Biol. 2007 Dec;135(2):145-8
pubmed: 17662516
Behav Res Ther. 1997 Jan;35(1):11-21
pubmed: 9009039
Subst Use Misuse. 2005;40(4):499-510
pubmed: 15830732
Sleep Breath. 2021 Mar 4;:
pubmed: 33661467
Behav Res Ther. 2008 Mar;46(3):296-321
pubmed: 18258216
Drug Alcohol Depend. 2019 Jul 1;200:95-114
pubmed: 31121495
Inj Epidemiol. 2019 Jul 1;6:32
pubmed: 31304078
Clin Psychol Rev. 2017 Mar;52:124-136
pubmed: 28119196
Br J Gen Pract. 2006 Dec;56(533):958-63
pubmed: 17132385
J Affect Disord. 1992 Apr;24(4):245-52
pubmed: 1578080
Br J Psychiatry. 2006 Sep;189:213-20
pubmed: 16946355
Eur Psychiatry. 2015 Nov;30(8):1037-47
pubmed: 26545257
Public Health Rep. 2016 Jul-Aug;131(4):536-43
pubmed: 27453597
Clin Psychol Psychother. 2008 Jan-Feb;15(1):1-14
pubmed: 19115423
Br J Psychiatry. 1991 Apr;158:511-6
pubmed: 1675901
J Affect Disord. 2002 Jul;70(2):133-41
pubmed: 12117625
Clin Neuropharmacol. 1987 Dec;10(6):538-44
pubmed: 3427560
Subst Abus. 2010 Apr;31(2):98-107
pubmed: 20408061
Am J Psychiatry. 2000 Dec;157(12):1973-9
pubmed: 11097963
Drug Alcohol Depend. 2015 Oct 1;155:1-7
pubmed: 26298552

Auteurs

Mélinée Chapoutot (M)

Association Nationale de Promotion des Connaissances sur Le Sommeil, 69001 Lyon, France.
Lyon Neuroscience Research Centre, CNRS UMR 5292-INSERM U1028, Lyon 1 University, 69005 Bron, France.

Laure Peter-Derex (L)

Association Nationale de Promotion des Connaissances sur Le Sommeil, 69001 Lyon, France.
Lyon Neuroscience Research Centre, CNRS UMR 5292-INSERM U1028, Lyon 1 University, 69005 Bron, France.
Sleep Medicine and Respiratory Disease Centre, Croix-Rousse Hospital, CHU of Lyon, 69004 Lyon, France.
Faculty of Medicine Lyon Sud-Charles Mérieux, Lyon 1 University, 69622 Villeurbanne, France.

Hélène Bastuji (H)

Lyon Neuroscience Research Centre, CNRS UMR 5292-INSERM U1028, Lyon 1 University, 69005 Bron, France.
Sleep Medicine and Respiratory Disease Centre, Croix-Rousse Hospital, CHU of Lyon, 69004 Lyon, France.
Faculty of Medicine Lyon Sud-Charles Mérieux, Lyon 1 University, 69622 Villeurbanne, France.

Wendy Leslie (W)

Xceltranslate, 06000 Nice, France.

Benjamin Schoendorff (B)

Institut de Psychologie Contextuelle, Montreal, QC H2Y 2S9, Canada.

Raphael Heinzer (R)

Centre D'Investigation et de Recherche Sur le Sommeil, CHUV, 1011 Lausanne, Switzerland.

Francesca Siclari (F)

Centre D'Investigation et de Recherche Sur le Sommeil, CHUV, 1011 Lausanne, Switzerland.

Alain Nicolas (A)

Lyon Neuroscience Research Centre, CNRS UMR 5292-INSERM U1028, Lyon 1 University, 69005 Bron, France.

Patrick Lemoine (P)

Association Nationale de Promotion des Connaissances sur Le Sommeil, 69001 Lyon, France.

Susan Higgins (S)

Centre Hospitalier Annecy Genevois, Service Pneumologie, 74000 Annecy, France.

Alexia Bourgeois (A)

Laboratory of Cognitive Neurorehabilitation, Faculty of Medicine, University of Geneva, 1201 Geneva, Switzerland.

Guillaume T Vallet (GT)

LAPSCO, Université Clermont Auvergne, CNRS, LAPSCO, 63000 Clermont-Ferrand, France.

Royce Anders (R)

Laboratoire EMC, Lyon 2 Université, 69500 Bron, France.

Marc Ounnoughene (M)

Cabinet de Psychiatrie du Plateau de Haye, 54320 Maxéville, France.

Jessica Spencer (J)

Faculty of Psychology, Swiss Distance Learning University, 3900 Brig, Switzerland.

Francesca Meloni (F)

Faculty of Psychology, Swiss Distance Learning University, 3900 Brig, Switzerland.

Benjamin Putois (B)

Association Nationale de Promotion des Connaissances sur Le Sommeil, 69001 Lyon, France.
Lyon Neuroscience Research Centre, CNRS UMR 5292-INSERM U1028, Lyon 1 University, 69005 Bron, France.
Faculty of Psychology, Swiss Distance Learning University, 3900 Brig, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH